Susquehanna International Group’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-15,300
Closed -$41K 13893
2022
Q4
$41K Buy
+15,300
New +$40.3K ﹤0.01% 11499
2022
Q3
Sell
-13,100
Closed -$65K 14454
2022
Q2
$65K Sell
13,100
-6,300
-32% -$33K ﹤0.01% 11820
2022
Q1
$138K Buy
19,400
+5,000
+35% +$41.4K ﹤0.01% 11630
2021
Q4
$262K Sell
14,400
-126,200
-90% -$2.72M ﹤0.01% 10814
2021
Q3
$2.75M Buy
140,600
+107,600
+326% +$4.09M ﹤0.01% 5133
2021
Q2
$1.48M Sell
33,000
-7,800
-19% -$362K ﹤0.01% 6680
2021
Q1
$2.05M Sell
40,800
-13,600
-25% -$927K ﹤0.01% 5855
2020
Q4
$4.86M Buy
+54,400
New +$4.58M ﹤0.01% 3445

Other funds holding CELL

Susquehanna International Group's CELL Position: Q2 2023 in Review

Susquehanna International Group sold out of PhenomeX Inc. Common Stock (CELL) in Q2 2023, closing a stake of 32,454 shares — an estimated $37.6K sold.

Susquehanna International Group first reported a position in CELL in Q4 2020 and held it in 10 quarters. The position peaked at $4.99M in Q1 2021. 84 funds tracked by Wall St. Rank hold CELL as of Q2 2023.

  • Susquehanna International Group reported no remaining PhenomeX Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Susquehanna International Group sold 32,454 PhenomeX Inc. Common Stock shares in Q2 2023, an estimated $37.6K.
  • Susquehanna International Group first reported a position in PhenomeX Inc. Common Stock in Q4 2020 and held it in 10 quarters.
  • Susquehanna International Group's PhenomeX Inc. Common Stock position peaked at $4.99M in Q1 2021.
  • 84 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.